GlassScriptPhysician profile
Franklin B Gluck
NPI 1154421055
$488.40
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $124.40 | 2019 | |
| Aquestive Therapeutics, INC. | $69.30 | 2019 | |
| Abbott Laboratories | $61.55 | 2019 | |
| Shire North American Group INC | $60.40 | 2019 | |
| Sanofi-Aventis U.S. LLC | $59.53 | 2019 | |
| Ucb, INC. | $45.47 | 2019 | |
| Amgen INC. | $29.67 | 2019 | |
| Genzyme Corporation | $24.63 | 2019 | |
| Biogen, INC. | $13.45 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Franklin Gluck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.